India and France have jointly inaugurated the Indo-French Centre for Artificial Intelligence in Health at AIIMS New Delhi. The state-of-the-art centre aims to harness AI for advancing precision medicine, diagnostics, drug discovery, and public health solutions combining French AI expertise with India’s vast clinical data and diverse patient population to tackle major health challenges.
Glimpse:
The Indo-French Centre for AI in Health will serve as a hub for collaborative research, training, and innovation. It will focus on AI applications in oncology, neurology, cardiology, infectious diseases, and maternal/child health, leveraging multimodal data (genomics, imaging, EHRs) to develop India-specific models. The initiative strengthens bilateral ties in healthtech and positions AIIMS as a global leader in clinically grounded AI research.
In a significant milestone for Indo-French cooperation in healthcare and technology, the Indo-French Centre for Artificial Intelligence in Health was formally inaugurated at the All India Institute of Medical Sciences (AIIMS) New Delhi. The centre was launched in the presence of high-level delegations from both countries, including representatives from the French Ministry of Health, Inserm, INRIA, and senior Indian officials from the Ministry of Health, DBT, and ICMR.
Core objectives and focus areas include:
AI for precision diagnostics improving early detection through multimodal imaging analysis (radiology, pathology, ophthalmology) Drug discovery & repurposing using AI to identify new therapeutic targets and repurpose existing drugs for neglected tropical diseases Predictive & preventive models forecasting disease progression, treatment response, and population-level risks Digital health equity developing multilingual, low-resource AI tools suitable for rural and underserved settings Capacity building joint training programs, PhD/postdoc exchanges, workshops, and clinician AI literacy initiatives
The centre will benefit from shared resources: access to large-scale Indian clinical datasets (anonymized and consented), French AI research infrastructure, and bilateral funding support.** It will adhere to strict ethical standards, data privacy (aligned with DPDP Act and GDPR), and transparent validation protocols to ensure patient safety and public trust.
This initiative builds on longstanding Indo-French collaboration in health (e.g., Pasteur Institute partnerships) and reflects both nations’ commitment to responsible AI that serves global public good. It is expected to produce high-impact publications, patents, and deployable tools within the next 3–5 years.
“AI must be shaped by the realities of patients and doctors. This centre will ensure that the power of AI serves India’s healthcare needs while upholding the highest standards of ethics and excellence.”
By
HB Team
Related News
